Skip to main content

Breast Cancer

Edited by: Dr Marc Lippman

The Breast Cancer Collection is an invitation-only sister title of the Springer subscription journal, Breast Cancer Research and Treatment (BREA).

Invited submissions should choose the Breast Cancer Collection during submission, and include the invitation letter from Dr Lippman in their SpringerPlus cover letter.

For more information about how you can be considered for the Breast Cancer Collection, please speak to the editorial team at BREA.

 

Collection Articles:

Page 4 of 4

  1. The aims of the study were to investigate the factors associated with not having breast reconstruction following mastectomy and to assess patient satisfaction with information on reconstruction.

    Authors: Delphine Héquet, Kevin Zarca, Sylvie Dolbeault, Benoît Couturaud, Charlotte Ngô, Virgine Fourchotte, Anne De La Rochefordière, Jean-Guillaume Féron, Alfred Fitoussi, Catherine Bélichard, Fabien Reyal, Fatima Laki, David Hajage, Brigitte Sigal, Bernard Asselain and Séverine Alran

    Citation: SpringerPlus 2013 2:325

    Content type: Review

    Published on:

  2. Bevacizumab, a humanized monoclonal antibody directed against vascular endothelial growth factor, is an effective and well-tolerated treatment option for patients with breast cancer. Bevacizumab has demonstrat...

    Authors: Vibeke Kruse, Hannelore Denys, Rudy Van Den Broecke, Simon Van Belle and Veronique Cocquyt

    Citation: SpringerPlus 2013 2:202

    Content type: Review

    Published on:

  3. Women receiving treatment for breast cancer commonly ingest herbal medicines. Little is known about the potential for herb-drug interactions in this population. The aim of this study is to investigate the effe...

    Authors: Janette Vardy, Haryana M Dhillon, Stephen J Clarke, Inger Olesen, Felicity Leslie, Anne Warby, Jane Beith, Anne Sullivan, Anne Hamilton, Philip Beale, Anneliese Rittau and Andrew J McLachlan

    Citation: SpringerPlus 2013 2:126

    Content type: Research

    Published on:

  4. The aim was to confirm a previously defined prognostic index, combining a proliferation marker, histological grade, and estrogen receptor (ER) in different subsets of primary N0/N1 chemo-naïve breast cancer pa...

    Authors: Carina Strand, Martin Bak, Signe Borgquist, Gunilla Chebil, Anna-Karin Falck, Marie-Louise Fjällskog, Dorthe Grabau, Ingrid Hedenfalk, Karin Jirström, Marie Klintman, Per Malmström, Hans Olsson, Lisa Rydén, Olle Stål, Pär-Ola Bendahl and Mårten Fernö

    Citation: SpringerPlus 2013 2:111

    Content type: Study protocol

    Published on:

  5. Time delay after an abnormal screening mammogram may have a critical impact on tumor size, stage at diagnosis, treatment, prognosis, and survival of subsequent breast cancer. This study was undertaken to evalu...

    Authors: Amelie G Ramirez, Eliseo J Pérez-Stable, Gregory A Talavera, Frank J Penedo, J Emilio Carrillo, Maria E Fernandez, Edgar Muñoz, Dorothy Long Parma, Alan EC Holden, Sandra San Miguel de Majors, Anna Nápoles, Sheila F Castañeda and Kipling J Gallion

    Citation: SpringerPlus 2013 2:84

    Content type: Research

    Published on:

  6. We previously reported that tumor mitochondrial redox state and its heterogeneity distinguished between the aggressive and the indolent breast cancer xenografts, suggesting novel metabolic indices as biomarker...

    Authors: He N Xu, Gang Zheng, Julia Tchou, Shoko Nioka and Lin Z Li

    Citation: SpringerPlus 2013 2:73

    Content type: Research

    Published on:

  7. Maximal oxygen uptake (VO2max) has been used to assess risk for all-cause mortality and cardiovascular disease (CVD), and low VO2max has recently been associated with increased mortality from breast cancer. The p...

    Authors: David Burnett, Patricia Kluding, Charles Porter, Carol Fabian and Jennifer Klemp

    Citation: SpringerPlus 2013 2:68

    Content type: Research

    Published on:

  8. Inflammatory breast cancer (IBC) is characterized by an apparent geographical distribution in incidence, being more common in North Africa than other parts of the world. Despite the rapid growth of immigrants ...

    Authors: Kelly A Hirko, Amr S Soliman, Mousumi Banerjee, Julie Ruterbusch, Joe B Harford, Robert M Chamberlain, John J Graff, Sofia D Merajver and Kendra Schwartz

    Citation: SpringerPlus 2013 2:3

    Content type: Research

    Published on:

  9. With the discovery of the BRCA1 gene and other genetic mutations associated with breast cancer, it has been established that hereditary mutations account for up to 5% of patients presenting with breast cancer.

    Authors: Lawal AbdulRazzaq Oluwagbemiga, Atoyebi Oluwole and Adesunkanmi AbdulRasheed Kayode

    Citation: SpringerPlus 2012 1:83

    Content type: Review

    Published on:

    The Erratum to this article has been published in SpringerPlus 2015 4:340

  10. Mammographic density (MD) is a strong risk factor for breast cancer and may represent a useful intermediate marker for breast cancer risk. Physical activity (PA) is known to be associated with a reduced risk o...

    Authors: Samera Azeem Qureshi, Merete Ellingjord-Dale, Solveig Hofvind, Anna H Wu and Giske Ursin

    Citation: SpringerPlus 2012 1:75

    Content type: Research

    Published on:

  11. Body mass index (BMI) is an independent risk factor for luminal-type breast cancer in Western populations. However, it is unclear whether the impact of BMI differs according to breast cancer subtype in Japanes...

    Authors: Aiko Sueta, Hidemi Ito, Tania Islam, Satoyo Hosono, Miki Watanabe, Kaoru Hirose, Takashi Fujita, Yasushi Yatabe, Hiroji Iwata, Kazuo Tajima, Hideo Tanaka, Hirotaka Iwase and Keitaro Matsuo

    Citation: SpringerPlus 2012 1:39

    Content type: Research

    Published on:

  12. The B-cell CLL/lymphoma 2 (BCL2) gene family encodes pro- and anti-apoptotic proteins that are critical regulators of programmed cell death. Higher levels of BCL2 expression in breast tumours have been shown t...

    Authors: Claire J Searle, Ian W Brock, Simon S Cross, Sabapathy P Balasubramanian, Malcolm W R Reed and Angela Cox

    Citation: SpringerPlus 2012 1:38

    Content type: Research

    Published on:

  13. Given that several targeted therapies directed towards folate receptor alpha (FRA) are in late stage clinical development, the sensitive and robust detection of FRA in tissues is of paramount importance relati...

    Authors: Daniel J O’Shannessy, Elizabeth B Somers, Julia Maltzman, Robert Smale and Yao-Shi Fu

    Citation: SpringerPlus 2012 1:22

    Content type: Research

    Published on:

  14. The spectrum of BRCA1/2 genetic variation in breast-ovarian cancer patients has been scarcely investigated outside Europe and North America, with few reports for South America, where Amerindian founder effects...

    Authors: Angela Rosaria Solano, Gitana Maria Aceto, Dreanina Delettieres, Serena Veschi, Maria Isabel Neuman, Eduardo Alonso, Sergio Chialina, Reinaldo Daniel Chacón, Mariani-Costantini Renato and Ernesto Jorge Podestá

    Citation: SpringerPlus 2012 1:20

    Content type: Study protocol

    Published on: